文献速递结核与非结核分枝杆菌医院感染防控

BCG疫苗对成人结核分枝杆菌感染的有效性:英国队列横断面分析

Effectiveness of BCG Vaccination Against Mycobacterium tuberculosis Infection in Adults: A Cross-sectional Analysis of a UK-Based Cohort.
PubMed 文献 · J Infect Dis · 2020-01-01

该研究基于英国结核病例成人接触者的队列数据,采用横断面分析评估BCG疫苗对潜伏性结核感染(LTBI)的保护效果。在3453名近期接触者中,27.5%存在LTBI;结论提示BCG与成人接触者LTBI患病率降低相关,且接种后超过20年仍可见保护迹象。

要点

  • 成人结核接触者中,BCG接种与LTBI患病率降低相关,疫苗有效性约30%。
  • BCG保护效果随时间推移而下降,但接种后超过20年仍可能有益。
  • 结果支持BCG不仅预防结核病,也可能减少结核分枝杆菌感染。

核心结论

  • BCG接种与成人结核接触者LTBI患病率降低相关,提示BCG可能预防结核分枝杆菌感染。

研究设计与样本

  • 英国队列研究中成人结核病例接触者的横断面分析,共纳入3453名近期接触者。
  • BCG接种状态依据卡痕或接种史确定,LTBI通过IGRA测量,采用多变量逻辑回归评估疫苗有效性。

主要发现

  • 3453名近期结核接触者中27.5%存在LTBI。
  • 疫苗有效性随接种后时间延长而下降,但接种后超过20年者LTBI患病率仍低于未接种者。

临床怎么用

  • 应继续将BCG接种作为结核控制策略的一部分,并考虑其对感染预防的潜在作用。
  • 对成人结核接触者评估LTBI时,可结合BCG接种史解读IGRA结果。

局限性

  • 横断面设计不能确定BCG与LTBI的时间先后关系。
  • BCG接种状态基于卡痕或接种史,可能存在错分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: BCG appears to reduce acquisition of Mycobacterium tuberculosis infection in children, measured using interferon-gamma release assays (IGRAs). We explored whether BCG vaccination continues to be associated with decreased prevalence of M. tuberculosis infection in adults. METHODS: We conducted a cross-sectional analysis of data from adult contacts of tuberculosis cases participating in a UK cohort study. Vaccine effectiveness (VE) of BCG, ascertained based on presence of a scar or vaccination history, against latent tuberculosis infection (LTBI), measured via IGRA, was assessed using multivariable logistic regression. The effects of age at BCG and time since vaccination were also explored. RESULTS: Of 3453 recent tuberculosis contacts, 27.5% had LTBI. There was strong evidence of an association between BCG and LTBI (adjusted odds ratio = 0.70; 95% confidence interval, .56-.87; P = .0017) yielding a VE of 30%. VE declined with time since vaccination but there was evidence that LTBI prevalence was lower amongst vaccinated individuals even >20 years after vaccination, compared with nonvaccinated participants. CONCLUSIONS: BCG is associated with lower prevalence of LTBI in adult contacts of tuberculosis. These results contribute to growing evidence that suggests BCG may protect against M. tuberculosis infection as well as disease. This has implications for immunization programs, vaccine development, and tuberculosis control efforts worldwide. CLINICAL TRIALS REGISTRATION: NCT01162265.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Katelaris AL, Jackson C, Southern J, et al. Effectiveness of BCG Vaccination Against Mycobacterium tuberculosis Infection in Adults: A Cross-sectional Analysis of a UK-Based Cohort. J Infect Dis. 2020. PMID: 31504674. doi:10.1093/infdis/jiz430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。